Launchpad Europe SPRL
Launchpad Europe reported total assets of 120,635 € at the end of the 2025 financial year (annual accounts filed with the NBB on 31 Aug 2026).
The score of Launchpad Europe shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2022 → 2025: Equity -31 % Total assets +27 %
Accounts of the company itself (not consolidated).
The full file covers 8 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
Launchpad Europe's annual accounts
Filed annual accounts
- Year ended 31 Dec 2025filed on 31 Aug 2026
- Year ended 31 Dec 2024filed on 28 Aug 2025
- Year ended 31 Dec 2023filed on 30 Aug 2024
- Year ended 31 Dec 2022filed on 01 Aug 2023
- Year ended 31 Dec 2021filed on 31 Aug 2022
Launchpad Europe's financial analysis
- Solvency35.1%sector median: 46.0%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of Launchpad Europe
Launchpad Europe's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0713.975.032
- VAT number
- BE0713975032
- Peppol
- Registered · 0208:0713975032 · as of 10 Nov 2026
- Legal form
- SPRL
- Incorporated
- 28 Nov 2018
- Registered office
- 8020 Oostkamp
- Latest accounts
- 2025 · filed on 31 Aug 2026
- Activity
- Wholesale of pharmaceutical and medical goods (NACE 46460)
Launchpad Europe (SPRL) has been based in Oostkamp since 2018, active in: wholesale of pharmaceutical and medical goods. For 2025, it reports a net profit of 7,827 € and equity of 42,343 €; its revenue is not published. Its solvency stands at 35.1%, below the median of its sector (46.0%).
Guide: Reading Belgian SME accounts: the five figures that count →
Companies similar to Launchpad Europe
Companies in the same business, of comparable size and area, outside its group.
- AstraZeneca Wholesale of pharmaceutical and medical goods Dilbeek · balance sheet €105.4m
- Laboratoire Colman Wholesale of pharmaceutical and medical goods La Louvière · balance sheet 42,584 €
- BIOCODEX Benelux Wholesale of pharmaceutical and medical goods Forest · balance sheet €8.15m
- Kenvue Belgium Wholesale of pharmaceutical and medical goods Antwerp · balance sheet €32.0m
- Melisana Wholesale of pharmaceutical and medical goods Evere · balance sheet €15.4m
- Teleflex Medical Wholesale of pharmaceutical and medical goods Brussels · balance sheet €8.88m
- Laboratoires Colin Wholesale of pharmaceutical and medical goods Liège · balance sheet 343,593 €
- Livanova Belgium Wholesale of pharmaceutical and medical goods Zaventem · balance sheet €38.8m
Frequently asked questions about Launchpad Europe
What is the revenue of Launchpad Europe?
Launchpad Europe files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of Launchpad Europe?
In Belgium, the VAT number is the company number prefixed with BE: BE0713975032 for Launchpad Europe, if the company is VAT-registered. Its company number (CBE) is 0713.975.032.
Where is the registered office of Launchpad Europe?
According to the CBE register, the registered office of Launchpad Europe is in 8020 Oostkamp.
What is the equity of Launchpad Europe?
At the close of the 2025 financial year, the equity of Launchpad Europe amounts to 42,343 €, a solvency of 35.1% of total assets.
Who manages Launchpad Europe?
The register lists 2 active mandates at Launchpad Europe. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of Launchpad Europe
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →